Senzime AB of Uppsala at MEDICA 2017 in Düsseldorf -- COMPAMED Trade Fair
OEM

Senzime AB

Vallvägen 4 A, 756 51 Uppsala
Sweden

Telephone +46 18 515640
Fax +46 18 515630
info@senzime.com

This company is co-exhibitor of
Business Sweden The Swedish Trade & Invest Council

Hall map

MEDICA 2017 hall map (Hall 3A): stand 3AE29

Fairground map

MEDICA 2017 fairground map: Hall 3A

Our range of products

Product categories

  • 01  Electromedical equipment / Medical Technology
  • 01.04  Intense medicine / anesthesiology / respiration
  • 01.04.04  Patient monitoring systems / Measuring stations

Patient monitoring systems / Measuring stations

  • 01  Electromedical equipment / Medical Technology
  • 01.04  Intense medicine / anesthesiology / respiration
  • 01.04.04  Patient monitoring systems / Measuring stations
  • 01.04.04.07  Operation monitoring equipment
  • 01  Electromedical equipment / Medical Technology
  • 01.04  Intense medicine / anesthesiology / respiration
  • 01.04.04  Patient monitoring systems / Measuring stations
  • 01.04.04.09  Patient monitors

Our products

Product category: Patient monitors

The next generation TOF-monitor

The arm can be tucked under surgical drape, no thumb access requiredicon-tickLess than 30 seconds start-up, no calibration needed
icon-tickEase of use with single-use electro-sensors and no cross-contamination
icon-tickPrecise & reliable information based on EMG technique
The new TetraGraph monitor stimulates, measures, analyzes and displays muscle function in surgical patients receiving neuromuscular blocking agents (NMBAs). The sequence is performed in real-time, and the system requires less than 30 sec. for set-up.

The unique, user-friendly system includes the TetraGraph monitor, TetraSens disposable electrosensors and the TetraCord connecting cable.

More Less

Product category: Patient monitoring systems / Measuring stations

The next generation of patient monitoring

Detects early signs of complicationsicon-tickEnables early diagnosis
icon-tickImproves treatment
icon-tickReduces hospital stays and health care costs

The CliniSenz Analyzer is the future for postoperative monitoring since the analyzer provides continuous unattended monitoring of patients and only requires small sample volumes for analysis. The results are specific and have high precision as the CliniSenz Analyzer works with enzyme-based heat flow detection integrated on a proprietary microfluidic chip. Interferences from other substances such as pharmaceuticals are thereby avoided. CliniSenz Analyzer is used together with OnZurf Probe and other types of microdialysis catheters.

More Less

Product category: Operation monitoring equipment

Specific and fast sampling from the surface of an organ

Continous samplingicon-tickCollect biomarkers
icon-tickMinor invasive
icon-tickMinor stress to the organ
Onzurf Probe is based on the microdialysis technique and is an advanced development of the commercial probes already in clinical use. The Onzurf Probe has a unique attachment site, which allows the probe to be easily placed on the surface of an organ without penetrating the tissue and causing unnecessary stress to the organ. Previous preclinical studies have demonstrated that measurements from the heart, liver and intestinal surface reflect the metabolic processes that occur in the heart muscle, the liver parenchyma and intestinal lumen.

OnZurf Probe is used mainly for postoperative continuous sampling of substances that can be measured with CliniSenz Analyzer. The technology also allows the use of the OnZurf Probe as a continuous microdialysis sampler in clinical and preclinical studies together with Clinisenz Analyzer or other analytical systems, such as HPLC (high-performance liquid chromatography).

More Less

About us

Company details

Senzimes solutions are designed to ensure maximum patient benefiticon-tickReduce complications associated with surgery
icon-tickReduce health care costs
Senzime develops unique patient-oriented monitoring systems that make it possible to assess patients’ biochemical and physiological processes before, during and after surgery. The portfolio of technologies includes bedside systems that enable automated and continuous monitoring of life-critical substances such as glucose and lactate in both blood and tissues, as well as systems to monitor patients’ neuromuscular function perioperatively and in the intensive care medicine setting.

The solutions are designed to ensure maximum patient benefit, reduce complications associated with surgery and anesthesia, and decrease health care costs. Senzime operates in growing markets that in Europe and the United States are valued in excess of SEK 10 billion. The Senzime AB (publ) share are listed on NASDAQ Stockholm First North. Short name: SEZI.

More Less